TP53 Mutation Is a Prognostic Factor in Lower Grade Glioma and May Influence Chemotherapy Efficacy

SIMPLE SUMMARY: Molecular biomarkers are utilised for the development of targeted therapy and diagnostic or prognostic tools and in strategising therapeutic approaches as they may have an effect in drug response. In lower-grade glioma (LGG), there are currently no established biomarkers that are ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Noor, Humaira, Briggs, Nancy E., McDonald, Kerrie L., Holst, Jeff, Vittorio, Orazio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582451/
https://www.ncbi.nlm.nih.gov/pubmed/34771529
http://dx.doi.org/10.3390/cancers13215362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582451/
https://www.ncbi.nlm.nih.gov/pubmed/34771529
http://dx.doi.org/10.3390/cancers13215362

Ejemplares similares